3,4-methylenedioxyamphetamine has been researched along with Hepatocellular Carcinoma in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H | 1 |
| Lan, H | 1 |
| Zhang, M | 1 |
| Zhao, F | 1 |
| An, N | 1 |
| Yi, C | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and Hepatocellular Carcinoma
| Article | Year |
|---|---|
TEA Domain Transcription Factor 1 Inhibits Ferroptosis and Sorafenib Sensitivity of Hepatocellular Carcinoma Cells.
Topics: 3,4-Methylenedioxyamphetamine; Carcinoma, Hepatocellular; Ferroptosis; Humans; Liver Neoplasms; Reac | 2023 |